Compare Amphastar Pharmaceuticals Inc (AMPH) vs Huntington Ingalls Industries Inc (HII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Huntington Ingalls Industries Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Huntington Ingalls Industries Inc trades at $327.5 (market cap $12.92B). The key difference: Huntington Ingalls Industries Inc is far larger — about 14.9× Amphastar Pharmaceuticals Inc's market cap, and Huntington Ingalls Industries Inc pays a 1.68% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | HII | |
|---|---|---|
Market Cap | $868.62M | $12.92B |
Sector | Health | Technology |
52-Week High | $30.81 | $453.73 |
52-Week Low | $16.87 | $265.40 |
Enterprise Value | $1.27B | $15.84B |
Dividend Yield | — | 1.68% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Huntington Ingalls Industries Inc
Huntington Ingalls is the largest military shipbuilder in the U.S. and a provider of professional services to government and industry partners, specializing in nuclear-powered submarines and aircraft carriers.
Read more on HII →
